CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
FlowOx is developing a home treatment device for Peripheral Arterial Disease (PAD), which affects millions globally. The project focuses on establishing clinical efficacy and economic viability to facilitate market entry and improve patient outcomes.
Peripheral Arterial Disease (PAD) is caused by the deposition of fatty material on the inner walls of peripheral arteries causing reducing perfusion and local nutrition to the muscles and skin.
The condition affect 202 million people globally and is increasing at a rate of 20% per annum due to an aging population and epidemic growth of diabetes.
The social costs amounts to $210 - 380 billion per annum.
Behavioural changes such as smoking cessation, healthy nutrition and exercise is recommended t…
OTIVIO AS
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Finland, Kempele
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
United Kingdom, Salford
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
United Kingdom, Bangor
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
